Acerus Pharmaceuticals Corporation (ASPCF) Stock Analysis
DELISTED
What happened to Acerus Pharmaceuticals Corporation (ASPCF) stock?
Acerus Pharmaceuticals Corporation (ASPCF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Acerus Pharmaceuticals Corporation (ASPCF). Acerus Pharmaceuticals Corporation focuses on developing, manufacturing, and marketing specialty pharmaceutical products for men's and women's health. Their key products include Natesto for testosterone replacement and Noctiva for nocturia, distributed through their salesforce and international partners.
Last analyzed: Mar 18, 2026Acerus Pharmaceuticals Corporation (ASPCF) Healthcare & Pipeline Overview
ASPCF OTC Market Information
ASPCF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ASPCF shares?
No. ASPCF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ASPCF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ASPCF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Acerus Pharmaceuticals Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.